Summary
Berkshire Hathaway Inc.'s Q1 2026 results show robust growth in total assets, increasing to $1.25 trillion from $1.22 trillion at the end of 2025. Net earnings attributable to Berkshire shareholders significantly improved to $10.1 billion, a substantial increase from $4.6 billion in the prior year's first quarter. This strong performance was driven by a notable rebound in investment gains, which shifted from a substantial loss in Q1 2025 to a lesser loss in Q1 2026, alongside solid contributions from operating businesses. The insurance underwriting segment demonstrated improved profitability, with pre-tax underwriting earnings rising to $2.3 billion from $1.7 billion, benefiting from the absence of significant catastrophe events in the current quarter compared to the prior year. The manufacturing, service, and retailing segments also showed resilience, with combined pre-tax earnings increasing to $4.2 billion. While the equity securities portfolio experienced an unrealized loss, realized gains on sold securities were significant, and the company maintained substantial liquidity with over $373 billion in cash, cash equivalents, and U.S. Treasury Bills. Management highlighted the acquisition of OxyChem for $9.5 billion in January 2026 as a key strategic move.
Financial Highlights
29 data points| Revenue | $93.67B |
| Operating Expenses | $79.93B |
| Interest Expense | $1.30B |
| Net Income | $10.18B |
Key Highlights
- 1Total assets grew to $1.25 trillion, up from $1.22 trillion at the end of 2025.
- 2Net earnings attributable to Berkshire shareholders surged to $10.1 billion in Q1 2026, up from $4.6 billion in Q1 2025.
- 3Insurance underwriting pre-tax earnings improved to $2.3 billion from $1.7 billion, aided by the absence of major catastrophe losses.
- 4Investment gains (losses) showed improvement, moving from a pre-tax loss of $6.4 billion in Q1 2025 to $1.6 billion in Q1 2026.
- 5Manufacturing, service, and retailing segments combined for pre-tax earnings of $4.2 billion, up from $4.0 billion in the prior year.
- 6Berkshire completed the acquisition of OxyChem for approximately $9.5 billion in January 2026.
- 7The company maintained substantial liquidity with $373.5 billion in cash, cash equivalents, and U.S. Treasury Bills as of March 31, 2026.